ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Auto-immunity"

  • Abstract Number: 638 • 2013 ACR/ARHP Annual Meeting

    Estrogen-Induced STAT1 and STAT4 Expression Is Estrogen Receptor α Dependent and IFNα Independent: A Novel Mechanism For Sex-Bias In Systemic Lupus Erythematosus Pathogenesis?

    Nicholas A. Young1, Giancarlo R. Valiente2, Lai-Chu Wu1, Michael Bruss3, Craig Burd4 and Wael N. Jarjour5, 1Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 2Medical Scientist Training Program, The Ohio State University College of Medicine, Columbus, OH, 3Division of Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 4Molecular Genetics, The Ohio State University Wexner Medical Center, Columbus, OH, 5Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a devastating multi-organ autoimmune disease displaying an overwhelming female predilection. Estrogen (E2) influences gene expression by binding to estrogen…
  • Abstract Number: 547 • 2013 ACR/ARHP Annual Meeting

    Anti Ribosomal P  Antibodies Accelerate Lupus Glomerulonephritis and Induce Lupus Nephritis In Naive Mice

    Dana Ben-Ami Shor1, Miri Blank2, Sandra Reuter3, Torsten Matthias4, Alexander Volkov5, Iris Barshack6 and Yehuda Shoenfeld7, 1Zabludowicz Center for Autoimmune Diseases, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel, 2Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affiliated to Sackler Faculty of Medicine,Tel Aviv University, Tel-Aviv, Tel-Aviv, Israel, 3AIRA e.V., AESKU.KIPP Institute, Wendelsheim, Germany, 4AESKU.Diagnostics GmbH & Co. KG, Wendelsheim, Germany, 5Institute of Pathology, Sheba Medical Center, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Tel-Aviv, Israel, 6Institute of Pathology, Sheba Medical Center, affiliated to Sackler Faculty of Medicine, Tel-Aviv University,Tel-Aviv, Tel-Aviv, Israel, 7Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Affiliated to Sackler Faculty of Medicine, Tel-Aviv University,Tel-Aviv, Tel-Aviv, Israel

    Background/Purpose: Circulating anti-phosphoribosomal protein antibodies (anti-Ribos.P) were found to be associated with lupus nephritis. We have assessed the direct role of anti-Ribos.P in the development…
  • Abstract Number: 2893 • 2013 ACR/ARHP Annual Meeting

    Intestinal Microbiota Plays a Critical Role In The Production Of Antinuclear Antibodies In Lymphopenia-Induced Autoimmunity

    Toshiki Eri1, Kimito Kawahata1, Mitsuru Imamura1, Takeyuki Kanzaki2, Lisa Akahira1, Kazuya Michishita1, Makoto Dohi1, Takeshi Tokuhisa3 and Kazuhiko Yamamoto4, 1Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2Internal Medicine, Yamanashi Prefectural Central Hospital, Yamanashi, Japan, 3Development Genetics, Graduate School of Medicine, Chiba University, Chiba city, Chiba, Japan, 4Department of Allergy and Rhaumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

    Background/Purpose: Production of antinuclear autoantibodies (ANAs) is one of the major characteristics of the systemic autoimmune diseases, such as systemic lupus erythematosus (SLE), but the…
  • Abstract Number: 2195 • 2013 ACR/ARHP Annual Meeting

    Expanding The Spectrum Of Recombination Activating Gene-1 Deficiency To Include Early Onset Autoimmunity

    Lauren A. Henderson1, Francesco Frugoni1, Gregory Hopkins2, Helen de Boer2, Sung-Yun Pai2,3, Yu Nee Lee1, Jolan E. Walter4, Melissa M. Hazen1 and Luigi D Notarangelo5,6, 1Division of Immunology, Boston Children's Hospital, Boston, MA, 2Division of Hematology and Oncology, Boston Children's Hospital, Boston, MA, 3Division of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, 4Division of Allergy/Immunology, Massachusetts General Hospital for Children, Boston, MA, 5Division of Immunology and The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, MA, 6Harvard Stem Cell Institute, Boston, MA

    Background/Purpose: We sought to identify the etiology of early onset autoimmunity and T cell lymphopenia in two siblings through genetic and functional studies.  Newborn screening…
  • Abstract Number: 1902 • 2013 ACR/ARHP Annual Meeting

    Characterization Of HLA-DRB1 Distribution By 3rd Hypervariable Region Sequence In Systemic Sclerosis and Control Populations

    Coline, A. Gentil1, Hilary S. Gammill1, Christine, T. Luu1 and J. Lee Nelson2, 1Immunogenetics, Fred Hutchinson Cancer Research Center, SEATTLE, WA, 2Immunogenetics D2-100, Fred Hutchinson Cancer Rsch, Seattle, WA

    Background/Purpose: HLA class II genes are associated with a wide spectrum of autoimmune diseases.  Specific alleles at the DRB1, DQA1 and DQB1 loci are associated…
  • Abstract Number: 1792 • 2013 ACR/ARHP Annual Meeting

    Inhibition Of Chemokine Receptors CCR1 and CCR6 As Promising Therapies For Autoimmune Diseases Such As Rheumatoid Arthritis and Psoriasis

    Daniel Dairaghi1, Penglie Zhang2, Manmohan Leleti2, Robert Berahovich3, Karen Ebsworth3, Linda Ertl3, Shichang Miao4, Zhenhua Miao3, Lisa Seitz3, Joanne Tan3, Matthew Walters3, Yu Wang3, Jay Powers5, Thomas J. Schall6 and Juan C. Jaen7, 1Biology, ChemoCentryx, Inc., Mountain View, CA, 2Chemistry, ChemoCentryx, Mountain View, CA, 3Biology, ChemoCentryx, Mountain View, CA, 4Pharmacokinetics, ChemoCentryx, Inc., Mountain View, CA, 5ChemoCentryx, Mountain View, CA, 6ChemoCentryx, Inc., Mountain View, CA, 7Discovery and Preclinical Development, ChemoCentryx, Inc., Mountain View, CA

    Background/Purpose:  Chemokines are key regulators of leukocyte activation and recruitment to sites of inflammation. Of particular relevance in rheumatoid arthritis (RA), the chemokine receptors CCR1…
  • Abstract Number: 1639 • 2013 ACR/ARHP Annual Meeting

    GWAS In Hispanic and Latin American Individuals Enriched For Amerindian Ancestry Identifies a New Locus Associated With Systemic Lupus Erythematosus

    Marta Eugenia Alarcon Riquelme1, Julie T. Ziegler2, Mary E. Comeau3, Elena Sanchez4, Bernado Pons-Estel5, Eduardo Acevedo6, Jorge Mariano Cucho6, Ignacio Garcia de la Torre7, Mario H. Cardiel8, Pedro Miranda9, Luis Cattogio10, Marco Maradiaga11, Jorge Esquivel-Valerio12, Jose F Moctezuma13, Mercedes Garcia14, Guillermo Berbotto15, Alejandra Babini16, Hugo Scherbarth17, Sergio Toloza18, Judith A James19, Teresa Tusie-Luna20, John B Harley21, Raphael Zidovetski22, Carl Langefeldt2 and Chaim O. Jacob23, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Wake Forest School of Medicine, Winston-Salem, NC, 3Wake Forest University Health Sciences, Winston-Salem, NC, 4King's College London, London, United Kingdom, 5Hospital Provincial de Rosario, Rosario, Argentina, 6Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru, 7Hospital General de Occidente, Zapopan, Mexico, 8Centro de Investigacion Clinica de Morelia, Morelia, Mexico, 9Universidad de Chile and Centro de Estudios Reumatologicos, Santiago de Chile, Chile, 10Hospital Italiano, Buenos Aires, Argentina, 11Hospital General de Culiacán, Culiacan, Sinaloa, Mexico, 12Hospital Universitario Dr. José Eleuterio González, Universidad Autonoma de Nuevo León, Nuevo Leon, Mexico, 13Hospital General de Mexico, Mexico, Mexico, 14Hospital San Martin, La Plata, Argentina, 15Hospital Eva Peron, Granadero Baigorria, Argentina, 16Hospital Privado de Cordoba, Cordoba, Argentina, 17H.I.G.A. Oscar E. Alende, Mar del Plata, Argentina, 18Hospital San Juan Bautista, Catamarca, Argentina, 19Oklahoma Medical Research Foundation, Oklahoma City, OK, 20Instituto de Investigaciones Biomédicas de la Universidad Nacional Autónoma de México, and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico, Mexico, 21Childrens Hospital, Cincinnati, OH, 22University of Southern California, Los Angeles, CA, 23Division of Rheumatology, University of Southern California Keck School of Medicine, Los Angeles, CA

    Background/Purpose: Systemic lupus erythematosus (SLE), a chronic autoimmune disease with a strong genetic component, exhibits a 9:1 female to male ratio and disproportionate impact on…
  • Abstract Number: 1621 • 2013 ACR/ARHP Annual Meeting

    T Helper 17 Cells and Interferon Type I: Partners In Crime In SLE?

    Odilia B.J. Corneth1, Zana Brkic2, Cornelia G. van Helden-Meeuwsen3, Radboud J.E.M. Dolhain4, Naomi I. Maria3, Sandra M.J. Paulissen4, Nadine Davelaar5, Jan Piet van Hamburg5, Paul L. Van Daele3, Virgil A. Dalm2, Martin van Hagen3, Marjan A. Versnel2 and Erik Lubberts6, 1Rheumatology and Immunology, Erasmus Medical Center, Rotterdam, Netherlands, 2Erasmus Medical Center, Immunology, Rotterdam, Netherlands, 3Immunology, Erasmus Medical Center, Rotterdam, Netherlands, 4Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands, 5Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 6Erasmus Medical Center, Rheumatology, Rotterdam, Netherlands

    Background/Purpose: A hallmark of systemic autoimmune diseases, such as systemic lupus erythematotsus (SLE), is the increased expression of interferon (IFN) type I inducible genes, the…
  • Abstract Number: 1699 • 2012 ACR/ARHP Annual Meeting

    Neutropenia After Rituximab in Rheumatoid Arthritis and Other Autoimmune Diseases Is a Rare Events : Date From the Autoimmunity and Rituximab Registry

    Jean Hugues Salmon1, Patrice Cacoub2, Bernard G. Combe3, Jean Sibilia4, Beatrice Pallot Prades5, Olivier Fain6, Alain G. Cantagrel7, Maxime Dougados8, Olivier Meyer9, Philippe Carli10, Edouard Pertuiset11, Isabelle Pane12, Philippe Ravaud13, Xavier Mariette14 and Jacques-Eric Gottenberg15, 1Rheumatology, Reims, France, 2Internal Medicine, Assistance Publique-Hôpitaux de Paris, Hopital Pitié-Salpétrière, Paris, France, 3Rhumatologie, Hopital Lapeyronie, Montpellier, France, 4Rheumatology, CHU Hautepierre, Strasbourg, France, 5Rheumatology department, Saint Etienne university hospital, Saint Etienne, France, 6Internal Medicine, Jean Verdier Hospital, Bondy, France, 7Rheumatology, Place du Docteur Baylac, Toulouse, France, 8Rheumatology B Department, Paris-Descartes University, APHP, Cochin Hospital, Paris, France, 9Rheumatology, Hopital Bichat, Paris, France, 10HIA sainte Anne, Toulon, France, 11Rheumatology, Ch Rene Dubos, Pontoise, France, 12Hotel Dieu University Hospital Paris, Hotel Dieu University Hospital Paris, Paris, France, 13Epidemiology, Hopital Hotel Dieu, Paris Descartes University, Paris, France, 14Rheumatology, Université Paris-Sud, Le Kremlin Bicetre, France, 15Rheumatology, Strasbourg University Hospital, Strasbourg, France

    Background/Purpose: Limited data are available regarding the proportion and severity of late onset neutropenia after RTX in large and unselected populations of patients with various…
  • Abstract Number: 1672 • 2012 ACR/ARHP Annual Meeting

    Myosin Skews Effector Immune Cells of Scurfy Mice to Target Muscles in an Adoptive Transfer Model of Myositis

    Nicholas Young1, Rahul Sharma2, Alexandra Friedman3, Benjamin Kaffenberger1 and Wael N. Jarjour4, 1Immunology and Rheumatology, The Ohio State University Medical Center, Columbus, OH, 2Medicine, University of Virginia Health System, Charlottesville, VA, 3Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 4Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: Myositis is associated with an inflammatory process that results in pronounced muscle weakness and is observed in some regulatory T cell (Treg) deficient mouse…
  • Abstract Number: 1649 • 2012 ACR/ARHP Annual Meeting

    French Cohort Study of 141 Cases of Autoimmune Congenital Heart Block

    Kateri Levesque1, Alice Maltret2, Mohamed Hamidou3, Moez Jallouli4, Jean Loup Pennaforte5, Pauline Orquevaux5, Jean-Charles Piette6, Zahir Amoura4, Francois Barriere7, Jérome Le Bidois2, Laurent Fermont2, Laurence Cohen8, Olivier Meyer9, Olivier Fain10, Arnaud Theulin11, Hugues Lucron12, Francois Sassolas13, Holly Bezanahary14, Gaëlle Guettrot-Imbert15, Pascal Seve16, Elizabeth Diot17, Nathalie Morel1, Christophe Deligny18, Elisabeth Villain2 and Nathalie Costedoat-Chalumeau19, 1Internal Medicine, Groupe Hospitalier Pitié-Salpétrière, Paris, France, 2Cardiology, Groupe Hospitalier Necker - Enfants Malades, Paris, France, 3Internal Medicine Department, Nantes University Hospital, Nantes, France, 4Department of Internal Medicine 2. Referal center for SLE/APS, CHU Pitié-Salpêtrière, Paris, France, 5Hu Robert Debre, CHU Reims, Reims, France, 6Hospital Pitie, Paris, 7Pediatry, CHU Nantes, Nantes, France, 8Cardiology, Institut Jacques Cartier, 9Rheumatology, Hopital Bichat, Paris, France, 10Internal Medicine, Service de médecine interne, Université Paris 13, AP-HP, Hôpital Jean Verdier, Bondy, France, 11Rheumatology, Strasbourg University Hospital, Strasbourg, France, 12Cardiology, CHU Fort-de-France, Fort de France, Martinique, 13Cardiology, CHU Lyon, Lyon, France, 14Internal Medicine, University Hospital of Limoges, Limoges, France, 15Internal Medicine, Hopital Gabriel Montpied, Clermont-Ferrand, France, 16Internal medicine, CHU Lyon, Lyon, France, 17Department of Internal Medicine, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire de Tours, Tours, France, Tours, France, 18Rhumatologie Et Médecine Interne, Centre hospitalier Universitaire de Fort de France, Fort de France, Martinique, 19Internal Medicine, Assistance Publique-Hôpitaux de Paris, Hopital Pitié-Salpétrière, Paris, France

    Background/Purpose: Cardiac neonatal lupus manifestations mainly include congenital heart block (CHB), endocardial fibroelastosis and dilated cardiomyopathy.  We report the preliminary results of the French registry…
  • Abstract Number: 1072 • 2012 ACR/ARHP Annual Meeting

    Enzymatic Lipid Oxidation Contributes to the Maintenance of Self-Tolerance by Regulating Antigen Clearance and Dendritic Cell Function

    Stefan Uderhardt1, Tobias Rothe1, Elisabeth Zinser2, Olga Oskolkova3, Martin Herrmann4, Alexander Steinkasserer5, Valery Bochkov3, Georg Schett6 and Gerhard Kronke1, 1Internal Medicine 3, University of Erlangen, Erlangen, Germany, 2University of Erlangen, Erlangen, Germany, 3Department of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria, Vienna, Austria, 4Instiute for Immunology, PhD, Erlangen, Germany, 5Department of Immune Modulation at the Department of Dermatology, University Hospital Erlangen, Erlangen, Germany, 6Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany

    Background/Purpose: During inflammation and tissue damage, pathogens as well as dying cells are ingested by different phagocytes such as macrophages and dendritic cells. The uptake…
  • Abstract Number: 979 • 2012 ACR/ARHP Annual Meeting

    Cell-Type Specific Type I Interferon Signatures in Systemic Lupus Erythematosus and Viral Infection: What Makes the Difference?

    Chieko Kyogoku1, Joachim R. Grün1, Tobias Alexander2, Robert Biesen3, Falk Hiepe4, Thomas Häupl3, Andreas Radbruch1 and Andreas Grützkau1, 1German Rheumatism Research Centre Berlin (DRFZ), an institute of the Leibniz Association, Berlin, Germany, 2Department of Rheumatology and Clinical Immunology, Charité – University Hospital, Berlin, Germany, 3department of Rheumatology and Clinical Immunology, Charité University Hospital Berlin, Berlin, Germany, 4Med. Klinik m. Sp. Rheumatologie und klin. Immunologie, Charité University Hospital Berlin, Berlin, Germany

    Background/Purpose: Gene expression profiling experiments using peripheral blood mononuclear cells (PBMCs) revealed a crucial role of type I interferon (IFN) in the pathogenesis of systemic…
  • Abstract Number: 685 • 2012 ACR/ARHP Annual Meeting

    Using a Library of Synthetic Autoantigen Mimics to Discover Biomarkers of Systemic Lupus Erythematosus

    Akshai Lakhanpal1, Jiexia Quan2, Sayed Zaman1, Nancy J. Olsen3 and David R. Karp2, 1Rheumatic Diseases Divsion, UT Southwestern Medical Center, Dallas, TX, 2Rheumatic Diseases Division, UT Southwestern Medical Center, Dallas, TX, 3Medicine, Penn State MS Hershey Medical Center, Hershey, PA

    Background/Purpose:   The natural history of systemic lupus erythematosus (SLE) is felt to evolve from a state of normal immunity to serologic autoimmunity and then…
  • Abstract Number: 686 • 2012 ACR/ARHP Annual Meeting

    Cell-Type Specific Type I Interferon Signatures in Autologous Stem Cell Transplanted Lupus Patients: Different Molecular Behavior Between CD4+ T Cells and Monocytes

    Chieko Kyogoku1, Joachim R. Grün1, Tobias Alexander2, Robert Biesen3, Falk Hiepe4, Thomas Häupl3, Andreas Radbruch1 and Andreas Grützkau1, 1German Rheumatism Research Centre Berlin (DRFZ), an institute of the Leibniz Association, Berlin, Germany, 2Department of Rheumatology and Clinical Immunology, Charité – University Hospital, Berlin, Germany, 3department of Rheumatology and Clinical Immunology, Charité University Hospital Berlin, Berlin, Germany, 4Med. Klinik m. Sp. Rheumatologie und klin. Immunologie, Charité University Hospital Berlin, Berlin, Germany

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease that affects multiple organs, whose pathology is mainly caused by the augmented interferon (IFN)…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology